4
Changes in Ownership
PHIBRO ANIMAL HEALTH CORP Filed Acc 0001104659-25-118545
President and CEO sold 7,040 shares at an average $41.00 ($288,607)
- President and CEO acquired 30,000 shares (conversion)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BENDHEIM JACK · President and CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-03 | Conversion : show line 1 in the form 10b5-1 | +30,000 | 56,800 | I | ||
| 2025-12-03 | Sale : show line 2 in the form 10b5-1 | −3,520 | $40.77 | $143,511 | 53,280 | I |
| 2025-12-04 | Sale : show line 3 in the form 10b5-1 | −3,152 | $41.16 | $129,731 | 50,128 | I |
| 2025-12-04 | Sale : show line 4 in the form 10b5-1 | −368 | $41.75 | $15,365 | 49,760 | I |
| Open-market sales · 7,040 sh · avg $41.00 · $288,607 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-03 | Conversion : show line 5 in the form 10b5-1 Class B Common Stock | −30,000 | 19,961,034 | I |
Loading xslF345X05/tm2532723-1_4seq1.xml…